cyclosporine has been researched along with Pulmonary Arterial Remodeling in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dardik, A; Furuyama (古山正), T; Gao (高喜翔), X; Gao (高明杰), M; Gonzalez, L; Kiwan, G; Komori (古森公浩), K; Langford, J; Liu (刘佳), J; Matsubara (松原裕), Y; Matsumoto (松本拓也), T; Taniguchi (谷口良輔), R; Yatsula, B | 1 |
Ali, RM; El-Gowelli, HM; El-Mas, MM; Helmy, MW | 1 |
2 other study(ies) available for cyclosporine and Pulmonary Arterial Remodeling
Article | Year |
---|---|
Inhibition of T-Cells by Cyclosporine A Reduces Macrophage Accumulation to Regulate Venous Adaptive Remodeling and Increase Arteriovenous Fistula Maturation.
Topics: Animals; Arteriovenous Shunt, Surgical; Cyclosporine; Female; Immunosuppressive Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Models, Animal; T-Lymphocytes; Vascular Remodeling | 2021 |
Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Celecoxib; Cyclosporine; Cytoprotection; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelins; Fibrosis; Heart Rate; Hypertension; Indomethacin; Male; Pyrazoles; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Renal Artery; Signal Transduction; Sulfonamides; Vascular Remodeling | 2015 |